Recruiting Lung Cancer Studies in New Hyde Park
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Multicenter, randomized, controlled, open-label, Phase 3 study designed to demonstrate that neladalkib (NVL-655) is superior to alectinib in prolonging progression-free survival (PFS) in patients with...
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
The main objective of the study will be to evaluate the efficacy of sutetinib maleate capsules in participants with locally advanced or metastatic non-small cell lung cancer NSCLC (uncommon EGFR mutat...
About Lung Cancer Clinical Trials in New Hyde Park
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in New Hyde Park, NY. These studies are seeking a combined 516 participants. Research is being sponsored by Nuvalent Inc., Teligene US. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in New Hyde Park — FAQ
Are there lung cancer clinical trials in New Hyde Park?
Yes, there are 2 lung cancer clinical trials currently recruiting in New Hyde Park, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Hyde Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Hyde Park research site will contact you about next steps.
Are clinical trials in New Hyde Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Hyde Park studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in New Hyde Park are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov